262 related articles for article (PubMed ID: 16879206)
1. Management of patients with refractory immune thrombocytopenic purpura.
George JN
J Thromb Haemost; 2006 Aug; 4(8):1664-72. PubMed ID: 16879206
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura.
Kojouri K; George JN
Int J Hematol; 2005 Feb; 81(2):119-25. PubMed ID: 15765779
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
[TBL] [Abstract][Full Text] [Related]
4. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
Kolonić SO; Patekar MB; Milunović V
Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
[TBL] [Abstract][Full Text] [Related]
6. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
7. Sequence of treatments for adults with primary immune thrombocytopenia.
George JN
Am J Hematol; 2012 May; 87 Suppl 1():S12-5. PubMed ID: 22389032
[TBL] [Abstract][Full Text] [Related]
8. Current options for the treatment of idiopathic thrombocytopenic purpura.
Arnold DM; Kelton JG
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
[TBL] [Abstract][Full Text] [Related]
9. Management of immune thrombocytopenic purpura in adults.
Stasi R; Provan D
Mayo Clin Proc; 2004 Apr; 79(4):504-22. PubMed ID: 15065616
[TBL] [Abstract][Full Text] [Related]
10. Management of adult idiopathic thrombocytopenic purpura.
Nakhoul IN; Kozuch P; Varma M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
[TBL] [Abstract][Full Text] [Related]
11. Current therapies in primary immune thrombocytopenia.
Pels SG
Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura.
Pasa S; Altintas A; Cil T; Danis R; Ayyildiz O
J Thromb Thrombolysis; 2009 Apr; 27(3):329-33. PubMed ID: 18311541
[TBL] [Abstract][Full Text] [Related]
13. Update on the management of immune thrombocytopenic purpura in children.
Tarantino MD; Bolton-Maggs PH
Curr Opin Hematol; 2007 Sep; 14(5):526-34. PubMed ID: 17934363
[TBL] [Abstract][Full Text] [Related]
14. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura.
Stasi R; Stipa E; Masi M; Cecconi M; Scimò MT; Oliva F; Sciarra A; Perrotti AP; Adomo G; Amadori S
Am J Med; 1995 May; 98(5):436-42. PubMed ID: 7733121
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and therapy of idiopathic thrombocytopenic purpura (ITP) in adults].
Chrobák L
Vnitr Lek; 2002 Aug; 48(8):773-80. PubMed ID: 12425210
[TBL] [Abstract][Full Text] [Related]
16. ITP and international guidelines: what do we know, what do we need?
Rodeghiero F; Ruggeri M
Presse Med; 2014 Apr; 43(4 Pt 2):e61-7. PubMed ID: 24656296
[TBL] [Abstract][Full Text] [Related]
17. New therapeutic options for adult chronic immune thrombocytopenic purpura: a brief review.
Panzer S
Vox Sang; 2008 Jan; 94(1):1-5. PubMed ID: 17973895
[TBL] [Abstract][Full Text] [Related]
18. Treatment of immune thrombocytopenic purpura in children : current concepts.
Shad AT; Gonzalez CE; Sandler SG
Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
[TBL] [Abstract][Full Text] [Related]
19. Very long-term remission induced by short-term rituximab monotherapy in a patient with heavily pretreated, chronic immune thrombocytopenic purpura.
Clausen MR; Segel E; Brandsborg M; d'Amore F
Eur J Haematol; 2011 Mar; 86(3):256-9. PubMed ID: 21166717
[TBL] [Abstract][Full Text] [Related]
20. Immune thrombocytopenic purpura in adults.
Godeau B; Provan D; Bussel J
Curr Opin Hematol; 2007 Sep; 14(5):535-56. PubMed ID: 17934364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
